Anti Asthmatic Drugs Flashcards
(37 cards)
Asthma symptoms
- Wheezing
- Dyspnoea
- Cough
- Chest tightness
Asthma Pathophysiology
- Airway inflammation
- Increased mucus secretion
- Constriction of bronchial smooth muscles
Drug categories
- Bronchodilators
- Anti-inflammatory drugs
- Monoclonal antibody
Bronchodilators types
- β₂ agonists
- Methyl xanthines
- Anticholinergics
- Leukotriene antagonists
Anti-inflammatory agents types
- Mast cell stabilisers
- Inhalational
- Systemic
Monoclonal antibody type
Anti-IgE antibody
β₂ agonists examples
SABA: salbutamol, terbutaline
LABA: salmeterol, formeterol
Methyl xanthines examples
- Theophylline
* Aminophylline
Anticholinergics examples
- Ipratropium bromide
* Tiotropium bromide
Leukotriene antagonists examples
- Montelukast
- Zafirlukast
- Sodium Cromoglicate
- Nedocromil
Mast cell stabilisers examples
- Sodium Cromoglicate
* Nedocromil
Inhalational anti-inflammatory agents examples
- Beclomethasone
- Budesonide
- Fluticasone
Systemic anti-inflammatory agents examples
- Hydrocortisone
* Prednisolone
Anti-IgE antibody example
Omalizumab
Salbutamol indication
- Used to terminate attacks
- Not suitable for prophylaxis
- Less cardiac side effects
Salmeterol, formeterol indication
• Used for maintenance therapy and nocturnal asthma
β₂ agonists side effects
- Headache, palpitations, tremors
- Repeated doses: cardiac arrythmia, death
- Metabolic: hypokalaemia, increased insulin secretion
Methyl xanthines MOA
- Decrease cAMP degradation by inhibiting phosphodiesterase
* Slow and sustained bronchial smooth muscle relaxation
Theophylline indication
Act as “controller agent” during asthma therapy
Theophylline adverse effects
- Overdose: hypertension, arrythmia, convulsion
- CNS: tremor, nausea, insomnia, anxiety
- CVS: palpitation, arrythmia, precordial pain
Theophylline drug interaction
- Increased plasma level with enzyme inhibitors (erythromycin)
- Decreased plasma level with enzyme inducers (rifampicin)
Ipratropium bromide MOA
• Blocks AcH muscarinic receptors and inhibits bronchoconstriction (M3)
Ipratropium bromide indication
- Used prophylactically
- Used with β₂ agonists in acute attack
- Main use in COPD
Leukotriene antagonists MOA
- Antagonise LT1 receptor mediated bronchoconstriction
- Bronchodilation, reduced sputum eosinophil count, suppression of bronchial inflammation and hyper reactivity
- Effective in aspirin induced asthma